SMBG
SMBG is a medical device with 11 clinical trials. Currently 2 active trials ongoing. Historical success rate of 85.7%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
85.7%
6 of 7 finished
14.3%
1 ended early
2
trials recruiting
11
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
CGM for Insulin-Treated T2DM During Post-Discharge Transition
Glucose Monitoring Comparison in Primary Care
Effects of Real-time Continuous Glucose Monitoring System on Hospital-to-home Transitional Blood Glucose Control
Effects of Novel Flash Glucose Monitoring System on Glycemic Control in Adult Patients With Type 1 Diabetes Mellitus
FreeStyle Libre 2 Flash Glucose Monitoring System Control Phase Study for Pediatric Patients - BG
Clinical Trials (11)
CGM for Insulin-Treated T2DM During Post-Discharge Transition
Glucose Monitoring Comparison in Primary Care
Effects of Real-time Continuous Glucose Monitoring System on Hospital-to-home Transitional Blood Glucose Control
Effects of Novel Flash Glucose Monitoring System on Glycemic Control in Adult Patients With Type 1 Diabetes Mellitus
FreeStyle Libre 2 Flash Glucose Monitoring System Control Phase Study for Pediatric Patients - BG
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
Effect of Real-time Continuous Glucose Monitoring System in Overweight or Obese Adults With Prediabetes
Effects of Telemonitoring and Telemedicine Service for Type 2 Diabetes Care
Three Approaches to Glucose Monitoring in Non-insulin Treated Diabetes
SMBG Protocols Predicting Glucose Levels in Senior Diabetes Mellitus With CAD
Blood Monitoring and Data Acquisition and Utilization in Patients With Type 2 Diabetes Treated With Insulin
All 11 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 11